Xcel Wealth Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$880K Sell
11,144
-2,267
-17% -$193K 0.21% 82
2026
Q1
$1.16M Sell
13,411
-32
-0.2% -$2.87K 0.32% 63
2025
Q4
$1.17M Sell
13,443
-200
-1% -$15.2K 0.3% 68
2025
Q3
$781K Hold
13,643
0.2% 78
2025
Q2
$805K Sell
13,643
-60
-0.4% -$3.88K 0.23% 73
2025
Q1
$1M Sell
13,703
-126
-0.9% -$10.4K 0.31% 63
2024
Q4
$1.14M Sell
13,829
-20
-0.1% -$1.58K 0.32% 58
2024
Q3
$991K Buy
13,849
+75
+0.5% +$5.29K 0.29% 62
2024
Q2
$943K Buy
13,774
+1,914
+16% +$114K 0.3% 61
2024
Q1
$636K Buy
+11,860
New +$638K 0.2% 73

Other funds holding GMED

Xcel Wealth Management's GMED Position: Q2 2026 in Review

Xcel Wealth Management reduced its Globus Medical (GMED) stake by 17% in Q2 2026, selling an estimated $193K and leaving 11,144 shares worth $880K. The position accounts for 0.21% of the portfolio, ranked #82.

Xcel Wealth Management first reported a position in GMED in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.17M in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Xcel Wealth Management held 11,144 shares of Globus Medical worth $880K as of Q2 2026.
  • Xcel Wealth Management sold 2,267 Globus Medical shares in Q2 2026, an estimated $193K.
  • Globus Medical made up 0.21% of Xcel Wealth Management's portfolio in Q2 2026, its #82 holding.
  • Xcel Wealth Management first reported a position in Globus Medical in Q1 2024 and has held it in 10 quarters since.
  • Xcel Wealth Management's Globus Medical position peaked at $1.17M in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Xcel Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.